Category: equities
Market Outlook for 2017 by Harsha Imperial (Kumar)
Dollar Index The US Dollar has developed a cycle ever since President Nixon removed the Gold Standard in August 1971. The average cycle from crest to trough lasts about […]
Commitment of Traders Report of Stock Indices by Harsha Imperial
The Dow Jones Futures COT Charts show Extreme Sentiments in the Net Positions of Large Speculative Traders & Commercial Traders. The Large Speculators Net Position is shown in […]
All about the buys this AM on the opening, imbalance from market on open orders about…
All about the buys this AM on the opening, imbalance from market on open orders about $400m
S&P 500 Futures; Pre-Federal Reserve Rate Hike RIP
MrTopStep has a trading rule, and its called ‘It takes days and weeks to knock the ESZ down and only one to bring it back.’ On Monday the S&P futures […]
S&P 500 Futures; Illiquidity Sparks Volatility, #iBoxx USD High Yield Corporate Bonds
There is a long list of obstacles facing the S&P 500 futures this week and we are not sure what tops the list; the fed raising rates, the beginning of […]
S&P 500 Futures; Fear Instead of Cheer – Crude Oil Down to $36.12
The holidays are supposed to be a time of year when people take vacations and cut back from the day to day ins and out of trading, but that’s not […]
S&P 500 Futures; Crude Oil Raining on the Christmas Parade
The holidays are supposed to be a happy time for the markets, but so far this year, they have been anything but happy. We knew going into the beginning of […]
‘S&P, Crude Oil, the Fed and the December Quad Witch’
High: 2073.00 Early Low: 2050.50 Last: 2062.20 DOWN 19 handles Volume: ESZ 2mil, and SPZ 8.3k; 4k of that was the SPZ/SPH spread..Yes it’s roll over in the S&P and […]
MrTopStep’s Index Futures Recap
Wednesday & The Late Day RIP Overnight on the heels of a 50+ point decline in the Tuesday session the ESU15:CME opened at the 1916 area and started climbing higher […]
Bull of the Day: Lannett (LCI) – Bull of the Day
Lannett Company, Inc. (LCI) is cashing in on the demand for generic drugs. This Zacks Rank #1 (Strong Buy) is expected to grow earnings by the triple digits in fiscal […]